Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

27. November 2025 10:46 ET | Quelle: Research and Markets

8MM Respiratory Syncytial Virus Prophylaxis Drug Forecast Report 2025: A $7.2 Billion Market by 2030, Prophylactic Options to Continue to Diversify Due to Strength of Late-stage Pipeline

Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Respiratory Syncytial Virus Prophylaxis: Eight-Market Drug Forecast and Market Analysis - Update" report has been added to ResearchAndMarkets.com's...
20. Dezember 2024 10:05 ET | Quelle: Research and Markets

8MM Respiratory Syncytial Virus Prophylaxis Market Drug Analysis Report: Prophylactic Options to Continue to Diversify Due to Strength of Late-Stage Pipeline - Forecast to 2030

Dublin, Dec. 20, 2024 (GLOBE NEWSWIRE) -- The "Respiratory Syncytial Virus Prophylaxis: Eight-Market Drug Forecast and Market Analysis - Update" report has been added to ResearchAndMarkets.com's...
31. August 2021 07:13 ET | Quelle: Research and Markets

Global Respiratory Syncytial Virus Markets, 2017-2020 & 2021-2027 - Increasing Disease Burden / Advent of Targeted Therapies / High Cost of Disease Management

Dublin, Aug. 31, 2021 (GLOBE NEWSWIRE) -- The "Global Respiratory Syncytial Virus Market Size and Epidemiology (8MM), By Drug Type (Synagis, Other), By Dosage Form (Oral, Other), By Treatment Type...
20. April 2021 06:53 ET | Quelle: Research and Markets

Global Respiratory Syncytial Virus (RSV) Therapeutics Market Report 2021-2027: U.S. Market is Estimated at $360.6 Million, While China is Forecast to Grow at 9.7% CAGR

Dublin, April 20, 2021 (GLOBE NEWSWIRE) -- The "Respiratory Syncytial Virus (RSV) Therapeutics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering....